Prospective Feasibility Study of Endobronchial Ultrasound Transbronchial

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05835713` - Total Intravenous Anesthesia for Rigid Bronchoscopy Using Remimazolam	N/A
Active, not recruiting	`NCT06266546` - Prophylactic Endobronchial Tranexamic Acid to Reduce Bleeding in Transbronchial Cryobiopsy	Phase 3
Completed	`NCT03903315` - Central Malignant Airway Obstructions: Medical Treatment Alone Versus Endoscopic and Medical Treatmen

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT05835713 - Total Intravenous Anesthesia for Rigid Bronchoscopy Using Remimazolam

N/A

Active, not recruiting

NCT06266546 - Prophylactic Endobronchial Tranexamic Acid to Reduce Bleeding in Transbronchial Cryobiopsy

Phase 3

Completed

NCT03903315 - Central Malignant Airway Obstructions: Medical Treatment Alone Versus Endoscopic and Medical Treatmen

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06250387
Study type	Interventional
Source	Fondation Hôpital Saint-Joseph
Contact	Amir HANNA
Phone	+33140942456
Email	a.hanna@ghpsj.fr
Status	Not yet recruiting
Phase	N/A
Start date	February 2024
Completion date	September 2024

Prospective Feasibility Study of Endobronchial Ultrasound Transbronchial Cryobiopsy (EBUS-TBCB 1.1 mm Probe) Among Patients With Mediastinal Lymphadenopathies — EBUS-CRYO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms